Biochemical Industry Leader Blue Marble Launches Regulation A+ Offering

MISSOULA, Mont., Feb. 22, 2017 /PRNewswire/ -- Blue Marble Biomaterials (Blue Marble), a specialty chemical manufacturer and technology provider, announced today that it is now offering equity shares to the public through a Regulation A+ offering that is qualified by the Securities and Exchange Commission. Interested individuals can view the offering circular and find out more about the offering at https://www.manhattanstreetcapital.com/blue-marble-biomaterials.

The first zero-waste chemical biorefinery in the United States, Blue Marble replicates processes found in nature to convert organic waste into natural, non-GMO chemicals. These chemicals replace the ever-present petroleum-based chemicals found in nearly every manufactured product around the world.

"I'm proud to say that this is a situation where everyone wins," said Blue Marble Co-CEO Colby Underwood. "With the participation of our investors, consumers have more access to clean, natural products, our partners benefit from converting cost centers to revenue streams, and Blue Marble and our investors reap the rewards of what we believe is a remarkably potent business model."

Underwood also pointed to a clear opportunity to reduce American overreliance on crude oil. "Ninety-five percent of manufactured goods we use every day contain chemicals made from crude oil," he said. "Our proprietary technologies provide environmentally friendly and natural alternatives."

Blue Marble focuses on producing chemical ingredients for the flavor, fragrance, and personal- care product industries. Recently, the company announced a partnership with Welch's, a global food manufacturer, to convert its leftover grape and apple pomace into all natural chemicals.

"Historically, investing in companies like Blue Marble has been a luxury available to only accredited or high-net-worth individuals," said Rod Turner, CEO of Manhattan Street Capital, a fundraising platform specializing in Regulation A+ offerings. "Now, even entry-level investors can take advantage of the opportunity to own shares in an innovative company that is leading the emerging biomaterials industry."

About Blue Marble Biomaterials

Blue Marble uses proprietary technologies to convert plant-based organic waste, such as used coffee grounds, wood chips, and tomato and grape pomace, into natural and non-GMO chemicals that replace chemicals derived from crude oil. www.bluemarblebio.com

AN OFFERING STATEMENT REGARDING THIS OFFERING HAS BEEN FILED WITH THE SEC. THE SEC HAS QUALIFIED THAT OFFERING STATEMENT, WHICH ONLY MEANS THAT THE COMPANY MAY MAKE SALES OF THE SECURITIES DESCRIBED BY THE OFFERING STATEMENT. IT DOES NOT MEAN THAT THE SEC HAS APPROVED, PASSED UPON THE MERITS OR PASSED UPON THE ACCURACY OR COMPLETENESS OF THE INFORMATION IN THE OFFERING STATEMENT. YOU MAY OBTAIN A COPY OF THE OFFERING CIRCULAR THAT IS PART OF THAT OFFERING STATEMENT FROM https://www.sec.gov/Archives/edgar/data/1462326/000114420417009889/v459701_253g2.htm

YOU SHOULD READ THE OFFERING CIRCULAR BEFORE MAKING ANY INVESTMENT.

SOURCE Blue Marble Biomaterials

Related Links

http://www.bluemarblebio.com